特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

人工血管:医療機器のパイプライン評価

Vascular Grafts - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 346859
出版日 ページ情報 英文 91 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.27円で換算しております。
人工血管:医療機器のパイプライン評価 Vascular Grafts - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月24日 ページ情報: 英文 91 Pages
概要

当レポートでは、人工血管のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 人工血管の概要

第3章 開発中の製品

  • 人工血管 - パイプライン製品:開発段階別
  • 人工血管 - パイプライン製品:地域別
  • 人工血管 - パイプライン製品:規制別
  • 人工血管 - パイプライン製品:承認予定日別
  • 人工血管 - 進行中の臨床試験

第4章 人工血管 - 開発中のパイプライン製品:企業別

  • 人工血管企業 - パイプライン製品:開発段階別
  • 人工血管 - パイプライン製品:開発段階別

第5章 人工血管企業と製品の概要

  • 3S BioMedical, Inc.
  • Anethon (Inactive)
  • ARISTE Medical
  • Cardiojustable LLC
  • CryoLife, Inc.
  • DSM Biomedical B.V.
  • Eqalix, Inc.
  • FIT Biotech Oy
  • Gel-Del Technologies, Inc.
  • Graftworx, LLC
  • Healionics Corporation
  • Innovia LLC
  • MultiGene Vascular Systems (MGVS) Ltd.
  • NuVascular Technologies Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • SurgaColl Technologies Ltd
  • Universidad de Los Andes
  • VesselTek BioMedical LLC
  • Xeltis AG

第6章 人工血管 - 最近の動向

第7章 付録

図表

図表

List of Tables

  • Table 1: Vascular Grafts - Pipeline Products by Stage of Development 9
  • Table 2: Vascular Grafts - Pipeline Products by Segment 10
  • Table 3: Vascular Grafts - Pipeline Products by Territory 11
  • Table 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
  • Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
  • Table 6: Vascular Grafts - Ongoing Clinical Trials 14
  • Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development 15
  • Table 8: Vascular Grafts - Pipeline Products by Stage of Development 17
  • Table 9: Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 10: Vascular Graft - Product Status 19
  • Table 11: Vascular Graft - Product Description 19
  • Table 12: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 13: Drug Eluting Vascular Graft - Product Status 20
  • Table 14: Drug Eluting Vascular Graft - Product Description 20
  • Table 15: Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 16: Topograft - Product Status 21
  • Table 17: Topograft - Product Description 21
  • Table 18: Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 19: BioFunc - APC Vascular Graft - Product Status 22
  • Table 20: BioFunc - APC Vascular Graft - Product Description 22
  • Table 21: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 22: Adjustable SPA Shunt - Product Status 23
  • Table 23: Adjustable SPA Shunt - Product Description 23
  • Table 24: Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 25: NeoVessel Vascular Graft - Product Status 24
  • Table 26: NeoVessel Vascular Graft - Product Description 24
  • Table 27: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 28: Xenograft Implant - Peripheral Vascular Disease - Product Status 25
  • Table 29: Xenograft Implant - Peripheral Vascular Disease - Product Description 25
  • Table 30: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 31: Synergraft Xenograft Vascular Graft - Product Status 26
  • Table 32: Synergraft Xenograft Vascular Graft - Product Description 26
  • Table 33: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 34: Lifeline TEBV - Lower Limb - Product Status 27
  • Table 35: Lifeline TEBV - Lower Limb - Product Description 27
  • Table 36: LifeLine TEBV - Pediatric - Product Status 28
  • Table 37: LifeLine TEBV - Pediatric - Product Description 28
  • Table 38: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 39: Small Diameter Vascular Graft - Product Status 29
  • Table 40: Small Diameter Vascular Graft - Product Description 29
  • Table 41: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 42: CardioVessel - Product Status 30
  • Table 43: CardioVessel - Product Description 30
  • Table 44: LCL Graft - Product Status 31
  • Table 45: LCL Graft - Product Description 31
  • Table 46: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 47: GTU X-Graft - Product Status 32
  • Table 48: GTU X-Graft - Product Description 32
  • Table 49: GTU X2-Graft - Product Status 33
  • Table 50: GTU X2-Graft - Product Description 33
  • Table 51: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 52: VasoGraft - Product Status 34
  • Table 53: VasoGraft - Product Description 34
  • Table 54: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 55: HUMACYL - Peripheral Artery Disease - Product Status 35
  • Table 56: HUMACYL - Peripheral Artery Disease - Product Description 35
  • Table 57: HUMACYL Graft - CABG - Product Status 36
  • Table 58: HUMACYL Graft - CABG - Product Description 36
  • Table 59: HUMACYL Graft - Vascular Trauma - Product Status 36
  • Table 60: HUMACYL Graft - Vascular Trauma - Product Description 37
  • Table 61: Humacyte Inc - Ongoing Clinical Trials Overview 38
  • Table 62: HUMACYL Graft - Vascular Trauma - A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma 39
  • Table 63: HUMACYL - Peripheral Artery Disease - A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-popliteal Bypass in Patients with Peripheral Arterial Disease 40
  • Table 64: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 65: 4mm Vascular Graft - Product Status 41
  • Table 66: 4mm Vascular Graft - Product Description 41
  • Table 67: LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 68: LifeSpan ePTFE Vascular Graft - Product Status 42

List of Figures

  • Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 9
  • Figure 2: Vascular Grafts - Pipeline Products by Segment 10
  • Figure 3: Vascular Grafts - Pipeline Products by Territory 11
  • Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
  • Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
  • Figure 6: Vascular Grafts - Ongoing Clinical Trials 14
目次
Product Code: GDME0899EPD

GlobalData's Medical Devices sector report, "Vascular Grafts - Medical Devices Pipeline Assessment, 2019" provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Vascular Grafts Overview 8

3 Products under Development 9

  • 3.1 Vascular Grafts - Pipeline Products by Stage of Development 9
  • 3.2 Vascular Grafts - Pipeline Products by Segment 10
  • 3.3 Vascular Grafts - Pipeline Products by Territory 11
  • 3.4 Vascular Grafts - Pipeline Products by Regulatory Path 12
  • 3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date 13
  • 3.6 Vascular Grafts - Ongoing Clinical Trials 14

4 Vascular Grafts - Pipeline Products under Development by Companies 15

  • 4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 15
  • 4.2 Vascular Grafts - Pipeline Products by Stage of Development 17

5 Vascular Grafts Companies and Product Overview 19

  • 5.1 Angiograft LLC Company Overview 19
    • 5.1.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.2 Ariste Medical LLC Company Overview 20
    • 5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.3 Aruga Technologies LLC Company Overview 21
    • 5.3.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Biosurfaces Inc Company Overview 22
    • 5.4.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.5 Cardiojustable LLC (Inactive) Company Overview 23
    • 5.5.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.6 Cardiovate Company Overview 24
    • 5.6.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.7 Colorado Therapeutics, LLC Company Overview 25
    • 5.7.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 CryoLife Inc Company Overview 26
    • 5.8.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 Cytograft Tissue Engineering Inc (Inactive) Company Overview 27
    • 5.9.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 DSM Biomedical BV Company Overview 29
    • 5.10.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.11 Eqalix Inc Company Overview 30
    • 5.11.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.12 FIT Biotech Oy Company Overview 32
    • 5.12.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.13 Gel-Del Technologies, Inc. Company Overview 34
    • 5.13.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.14 Humacyte Inc Company Overview 35
    • 5.14.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.15 Innovia LLC Company Overview 41
    • 5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.16 LeMaitre Vascular Inc Company Overview 42
    • 5.16.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.17 Merit Medical Systems Inc Company Overview 44
    • 5.17.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.18 Nationwide Children's Hospital Company Overview 45
    • 5.18.1 Nationwide Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.19 Northwestern University Company Overview 46
    • 5.19.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.20 Peca Labs Inc Company Overview 47
    • 5.20.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 47

6 Vascular Grafts- Recent Developments 64

  • 6.1 Nov 04, 2019: PQ Bypass initiates pivotal study of next-generation advancement in Stent Graft Technology for Treatment of Patients with Peripheral Artery Disease 64
  • 6.2 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 64
  • 6.3 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 65
  • 6.4 Oct 23, 2019: LeMaitre Vascular announces Q3 2019 financial results 67
  • 6.5 Oct 15, 2019: LifeNet Health establishes world's first dedicated regenerative medicine logistics and distribution center in Indianapolis 68

7 Appendix 88

  • 7.1 Methodology 88
  • 7.2 About GlobalData 91
  • 7.3 Contact Us 91
  • 7.4 Disclaimer 91